Diabetic Nephropathy
Chronic Kidney Disease
Reducing CV Disease...
pathophysiology and therapy of diabetic nephropathy
WHO-P ACKAGE OF E SSENTIAL NCD I NTERVENTION - SCHC E XPERIENCE Southern Community Health Center – Peleliu. 2014 - Tukana Korovou.
Irbesartan Diabetic Nephropathy Trial (IDNT) Collaborative Study Group N Eng J Med 345:851-860, 2001 Edmund J. Lewis, M.D. Muehrcke Family Professor of.
Hypertension Control and Progression of Renal Disease u In clinical trials, a slower rate of decline in GFR is noted in those who achieved a BP of 130/80.
Discussion
K.Ounaissa, H.Jammoussi, A.Kacem, Ch.Amrouche, I.Ben Ahmed, O.Berriche, S.Blouza.
Discussion Glycemia may not be all bad! – While it may promote atherosclerosis generally, plaques so formed may be more stable (less vulnerable). – Result.
Diabetic nephropathy Dr,Sh.Sajjadieh Nephrologist.
